Benefits and risks of valproate sodium and related products should be carefully weighed when prescribing these drugs to women of childbearing age.
Tags: MedWatch Safety Alerts
The U.S. Food and Drug Administration has announced that Howard Sousa, doing business as the Artery Health Institute LLC, and DeSousa LLC, in New York, N.Y., has signed a consent decree of permanent injunction. The consent decree prohibits Sousa from distributing products with claims in the labeling to cure, treat, mitigate or prevent diseases.
Tags: fda press release
One lot recalled due to the presence of trace amounts of a 2,4,6-tribromoanisole (TBA), which has been associated with temporary and non-serious gastrointestinal symptoms.
Tags: MedWatch Safety Alerts